Elizabeth Holmes is in prison for having defrauded investors through her blood test company, Theranos. In the meantime, his partner begins one of his family.
Billy Evans, who has two children with Ms. Holmes, is trying to collect funds for a company that is described as “the future of diagnostics” and “a radically new approach to health tests”, according to the marketing equipment examined by the New York Times.
If it seems familiar, it is because Theranos was targeting in a similar way to revolutionize diagnostic tests. The Silicon Valley start-up captured the attention of the world by affirming, falsely in the end, having developed a blood test device which could execute a series of complex laboratory tests from a simple finger stitch.
The company of Mr. Evans is called Hanthus, which is a flower also known as Blood Lily. He plans to start by testing pets for diseases before progressing to humans, according to two investors presented on the company who spoke under the cover of anonymity because they had agreed to keep the plans secret. The marketing equipment of Mr. Evans, which hopes to collect more than $ 50 million, says that the ultimate goal is nothing less than “the optimization of human health”.
A photo provided to potential investors in the prototype of the start-up has more than a physical resemblance that passes with the infamous blood test machine of Theranos, known as Edison or Minilab. The device that Mr. Evans’s company develops is a rectangular machine with a door, a digital display screen and what investor materials describe as lasers tinking inside.
Thank you for your patience while we check the access. If you are in reader mode, please leave and connect to your Times account, or subscribe to all time.
Thank you for your patience while we check the access.
Already subscribed? Connect.
Want all the time? Subscribe.